Mexico City, Mexico

Orestes Martinez

This inventor holds 1 USPTO granted patent. Top assignee: Fermic S.a. De C.v.. Active years: 2002.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Orestes Martinez: Innovator in Pharmaceutical Chemistry

Introduction

Orestes Martinez is a notable inventor based in Mexico City, MX. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of simvastatin, a widely used cholesterol-lowering medication. His innovative methods have enhanced the efficiency and purity of simvastatin production.

Latest Patents

Orestes holds a patent for a method that alkylates the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin. This method allows for the production of simvastatin in high yield and pharmaceutical purity. The process involves forming an amide of lovastatin and protecting the free hydroxyl groups with hexamethyldisilazane (HMDS). The protected lovastatin amide undergoes methylation to form a protected simvastatin amide, which can be hydrolyzed to produce simvastatin acid. The method is advantageous as it avoids the production of acid during the reaction, simplifying the purification process.

Career Highlights

Orestes Martinez is associated with Fermic S.A. de C.V., where he applies his expertise in pharmaceutical chemistry. His work has been instrumental in advancing methods for drug synthesis, contributing to the pharmaceutical industry’s ability to produce high-quality medications.

Collaborations

Orestes has collaborated with notable colleagues, including Edvige Galeazzi and Gustavo A. Garcia. These partnerships have fostered innovation and enhanced the research capabilities within his field.

Conclusion

Orestes Martinez is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the production of simvastatin. His innovative methods and collaborations continue to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…